479 related articles for article (PubMed ID: 26188466)
1. Chromatin deregulation in disease.
Mirabella AC; Foster BM; Bartke T
Chromosoma; 2016 Mar; 125(1):75-93. PubMed ID: 26188466
[TBL] [Abstract][Full Text] [Related]
2. [Epigenetics' implication in autism spectrum disorders: A review].
Hamza M; Halayem S; Mrad R; Bourgou S; Charfi F; Belhadj A
Encephale; 2017 Aug; 43(4):374-381. PubMed ID: 27692350
[TBL] [Abstract][Full Text] [Related]
3. Epigenomics in stress tolerance of plants under the climate change.
Kumar M; Rani K
Mol Biol Rep; 2023 Jul; 50(7):6201-6216. PubMed ID: 37294468
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic Regulation in Neurodegenerative Diseases.
Berson A; Nativio R; Berger SL; Bonini NM
Trends Neurosci; 2018 Sep; 41(9):587-598. PubMed ID: 29885742
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic Mistakes in Neurodevelopmental Disorders.
Mastrototaro G; Zaghi M; Sessa A
J Mol Neurosci; 2017 Apr; 61(4):590-602. PubMed ID: 28255957
[TBL] [Abstract][Full Text] [Related]
6. Targeting epigenetics as a promising therapeutic strategy for treatment of neurodegenerative diseases.
Zhang L; Liu Y; Lu Y; Wang G
Biochem Pharmacol; 2022 Dec; 206():115295. PubMed ID: 36241096
[TBL] [Abstract][Full Text] [Related]
7. Epigenetics in cancer: targeting chromatin modifications.
Ellis L; Atadja PW; Johnstone RW
Mol Cancer Ther; 2009 Jun; 8(6):1409-20. PubMed ID: 19509247
[TBL] [Abstract][Full Text] [Related]
8. Epigenetics of Aging and Aging-Associated Diseases.
Saul D; Kosinsky RL
Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33401659
[TBL] [Abstract][Full Text] [Related]
9. Reprogramming of the epigenome in neurodevelopmental disorders.
Wilson KD; Porter EG; Garcia BA
Crit Rev Biochem Mol Biol; 2022 Feb; 57(1):73-112. PubMed ID: 34601997
[TBL] [Abstract][Full Text] [Related]
10. Targeting Chromatin Remodeling for Cancer Therapy.
Kaur J; Daoud A; Eblen ST
Curr Mol Pharmacol; 2019; 12(3):215-229. PubMed ID: 30767757
[TBL] [Abstract][Full Text] [Related]
11. What can clinical immunology learn from inborn errors of epigenetic regulators?
Camacho-Ordonez N; Ballestar E; Timmers HTM; Grimbacher B
J Allergy Clin Immunol; 2021 May; 147(5):1602-1618. PubMed ID: 33609625
[TBL] [Abstract][Full Text] [Related]
12. Epigenetics.
Jain R; Epstein JA
Adv Exp Med Biol; 2024; 1441():341-364. PubMed ID: 38884720
[TBL] [Abstract][Full Text] [Related]
13. Dietary polyphenols and chromatin remodeling.
Russo GL; Vastolo V; Ciccarelli M; Albano L; Macchia PE; Ungaro P
Crit Rev Food Sci Nutr; 2017 Aug; 57(12):2589-2599. PubMed ID: 26357880
[TBL] [Abstract][Full Text] [Related]
14. Chromatin in nervous system development and disease.
Iwase S; Martin DM
Mol Cell Neurosci; 2018 Mar; 87():1-3. PubMed ID: 29248671
[TBL] [Abstract][Full Text] [Related]
15. Contribution of spurious transcription to intellectual disability disorders.
Scandaglia M; Barco A
J Med Genet; 2019 Aug; 56(8):491-498. PubMed ID: 30745423
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic regulation of epidermal differentiation.
Perdigoto CN; Valdes VJ; Bardot ES; Ezhkova E
Cold Spring Harb Perspect Med; 2014 Feb; 4(2):. PubMed ID: 24492849
[TBL] [Abstract][Full Text] [Related]
17. Mendelian disorders of the epigenetic machinery: postnatal malleability and therapeutic prospects.
Fahrner JA; Bjornsson HT
Hum Mol Genet; 2019 Nov; 28(R2):R254-R264. PubMed ID: 31595951
[TBL] [Abstract][Full Text] [Related]
18. Histone profiles in cancer.
Riedel SS; Neff T; Bernt KM
Pharmacol Ther; 2015 Oct; 154():87-109. PubMed ID: 26210403
[TBL] [Abstract][Full Text] [Related]
19. Advances in epigenetics and epigenomics for neurodegenerative diseases.
Qureshi IA; Mehler MF
Curr Neurol Neurosci Rep; 2011 Oct; 11(5):464-73. PubMed ID: 21671162
[TBL] [Abstract][Full Text] [Related]
20. Chromatin gatekeeper and modifier CHD proteins in development, and in autism and other neurological disorders.
Muhammad T; Pastore SF; Good K; Ausió J; Vincent JB
Psychiatr Genet; 2023 Dec; 33(6):213-232. PubMed ID: 37851134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
